Cite
HARVARD Citation
Borghetti, A. et al. (2018). Efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicentre cohort of patients with suppressed HIV‐1 replication. HIV medicine. 19 (7), pp. 452-454. [Online].